| __timestamp | Dr. Reddy's Laboratories Limited | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 21954000000 |
| Thursday, January 1, 2015 | 42585000000 | 21203000000 |
| Friday, January 1, 2016 | 45702000000 | 19945000000 |
| Sunday, January 1, 2017 | 46372000000 | 21420000000 |
| Monday, January 1, 2018 | 46910000000 | 22540000000 |
| Tuesday, January 1, 2019 | 48890000000 | 22178000000 |
| Wednesday, January 1, 2020 | 50129000000 | 22084000000 |
| Friday, January 1, 2021 | 54559000000 | 20118000000 |
| Saturday, January 1, 2022 | 62081000000 | 19046000000 |
| Sunday, January 1, 2023 | 105931000000 | 20112000000 |
| Monday, January 1, 2024 | 77201000000 | 21969000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Johnson & Johnson and Dr. Reddy's Laboratories Limited have showcased contrasting trends in their SG&A expenditures. From 2014 to 2023, Dr. Reddy's Laboratories saw a staggering 173% increase in SG&A expenses, peaking in 2023. In contrast, Johnson & Johnson maintained a relatively stable SG&A expenditure, with minor fluctuations around the $21 billion mark.
This divergence highlights differing strategic approaches. Dr. Reddy's aggressive expansion and market penetration efforts are evident, while Johnson & Johnson's steady approach suggests a focus on operational efficiency. Notably, the data for 2024 is incomplete, leaving room for speculation on future trends. As these industry titans continue to navigate global markets, their SG&A strategies will remain a key indicator of their competitive positioning.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Breaking Down SG&A Expenses: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Johnson & Johnson and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared